Apyx Medical (APYX) EBIT Growth (1y) (2012 - 2026)
Apyx Medical (APYX) EBIT Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.56% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 11.83% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -11.06% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 19.54% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 20.97% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -18.12% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 74.18% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 90.95% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 46.60% |
| 10 | Apyx Medical | 205.37 Mn | 174.49 Mn | 7.93 Mn | 70.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.14% |
| Dec 31, 2025 | 237.20% |
| Sep 30, 2025 | 77.11% |
| Jun 30, 2025 | 53.60% |
| Mar 31, 2025 | 53.88% |
| Dec 31, 2024 | 47.23% |
| Sep 30, 2024 | 21.61% |
| Jun 30, 2024 | -349.15% |
| Mar 31, 2024 | -17.89% |
| Dec 31, 2023 | 2.65% |
| Sep 30, 2023 | 19.80% |
| Jun 30, 2023 | 79.33% |
| Mar 31, 2023 | 4.43% |
| Dec 31, 2022 | -250.65% |
| Sep 30, 2022 | -45.72% |
| Jun 30, 2022 | -47.81% |
| Mar 31, 2022 | -23.73% |
| Dec 31, 2021 | 17.58% |
| Sep 30, 2021 | 9.22% |
| Jun 30, 2021 | 34.44% |